Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Parameter-efficient fine-tuning enables scalable transfer of regulatory sequence models to novel contexts.
PMID 41618434 · PMC12930932 · Genome biology · 2026 · 8 claims · 7 setups
PEFT enables accurate transfer of Borzoi to new datasets while significantly reducing GPU memory and runtime compared to joint training or full fine-tuning
-
Full-text index only
NELF prevents transcriptional readthrough into DNA replication zones in cancer cells.
PMID 41721097 · PMC13076867 · EMBO reports · 2026 · 8 claims · 8 setups
NELFCD transcript and NELF subunit protein levels are significantly upregulated in colorectal tumors (COAD/READ) relative to normal tissue
-
Full-text index only
bayesReact: expression-coupled regulatory motif analysis detects microRNA activity across cancers, tissues, and at the single-cell level.
PMID 41657247 · PMC12884093 · Nucleic acids research · 2026 · 8 claims · 6 setups
bayesReact is a novel fully Bayesian generative model for inferring regulatory motif (e.g., miRNA) activity from bulk or single-cell expression data
-
Full-text index only
Alternative splicing-triggered mRNA decay informs splice-switching targets for neurodevelopmental disorders.
PMID 41678398 · PMC13078869 · The Journal of clinical investigation · 2026 · 7 claims · 12 setups
EANMD, a new computational tool, identifies AS-NMD exons using the 50 nt rule plus additional transcript-level features and outperforms existing tools (SpliceTools, NMD Classifier)
-
Has reproduction · 73
Involvement of N4BP2L1, PLEKHA4, and BEGAIN genes in breast cancer and muscle cell development.
PMID 38859961 · PMC11163233 · Frontiers in cell and developmental biology · 2024 · 8 claims · 8 setups
N4BP2L1, PLEKHA4, and BEGAIN, normally highly expressed in breast myoepithelial and smooth muscle cells, are significantly downregulated in breast tumor tissue of a 50-patient cohort